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Salinomycin is a polyether antibiotic with properties of an ionophore, which is commonly used as cocciodiostatic drug and has
been shown to be highly effective in the elimination of cancer stem cells (CSCs) both in vitro and in vivo. One important caveat
for the potential clinical application of salinomycin is its marked neural and muscular toxicity. In the present study we show that
salinomycin in concentrations effective against CSCs exerts profound toxicity towards both dorsal root ganglia as well as
Schwann cells. This toxic effect is mediated by elevated cytosolic Na
þ concentrations, which in turn cause an increase of
cytosolicCa
2þ bymeansofNa
þ/Ca
2þ exchangers(NCXs)intheplasmamembraneaswellasthemitochondria.ElevatedCa
2þ
then leads to calpain activation, which triggers caspase-dependent apoptosis involving caspases 12, 9 and 3. In addition,
cytochrome c released from depolarized mitochondria directly activates caspase 9. Combined inhibition of calpain and the
mitochondrial NCXs resulted in signiﬁcantly decreased cytotoxicity and was comparable to caspase 3 inhibition. These ﬁndings
improve our understanding of mechanisms involved in the pathogenesis of peripheral neuropathy and are important to devise
strategies for the prevention of neurotoxic side effects induced by salinomycin.
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Salinomycin is a monocarboxylic polyether antibiotic that is
produced by a Streptomyces albus strain and acts as an
ionophore.
1 Itis widely used asanantiprotozoal agent against
coccidial parasites, for example in poultry farming and as a
growth promoter in chicken, pigs as well as ruminants. Its
mechanism of action involves the formation of lipid-soluble
complexes with cations, thereby facilitating bidirectional ion
ﬂux through lipid barriers by passive diffusion processes.
1
There is increasing interest in the development of salinomycin
as a potential clinical treatment for cancer, as it was shown
in a high-throughput screen that salinomycin is a highly
effective agent in the elimination of cancer stem cells
(CSCs).
2 In addition, there is emerging evidence that it
may also sensitize cancer cells to cytostatic drugs such
as doxorubicin.
3 Established treatment strategies for
various tumors kill the majority of tumor cells, but fail to
remove CSCs, which then are thought to be responsible for
local relapses and distant metastases. An effective therapy
against this tumor cell population is therefore of great clinical
signiﬁcance.
One important caveat for the potential clinical use of
salinomycin is its severe toxicity. A number of incidents
occurred in the past, where the substance was accidentally
fed or ingested in higher doses.
4 One particularly notable
episode occurred with salinomycin-contaminated cat food in
the Netherlands in 1996. Poisoned cats developed a severe
sensorimotor polyneuropathy with acute hind-limb paralysis,
which in some cases progressed to tetraparalysis, respiratory
failure and death. Post-mortem studies showed a combined,
predominantly axonal but also demyelinating neuropathy.
5
Peripheral nerve degeneration was also reported in dogs for
the salinomycin derivative narasin.
6 In a case of incidental
human poisoning by salinomycin, rhabdomyolysis but also
decreased reﬂexes suggestive of peripheral nerve lesions
were reported.
4
The precise mechanism of salinomycin-mediated neuro-
toxicity is not known. Interestingly, it was observed that
salinomycin alters cytosolic calcium (Ca
2þ) concentrations in
rabbit hearts,
7 and it was shown to inhibit mitochondrial
function in isolated mitochondria.
8 We therefore aimed to
determine the effects of salinomycin on cell viability as well as
the ional homeostasis of murine dorsal root ganglia neurons
(DRGNs), and attempted to characterize the resulting down-
stream effector mechanisms. We found that salinomycin
strongly reduces cell viability by means of calpain and
cytochrome c mediated caspase 9 and subsequent caspase
3 activation. Furthermore, we observed an increase of
cytosolic Na
þ concentrations, which leads to an increase of
cytosolic Ca
2þ through the Na
þ/Ca
2þ exchangers (NCXs) in
the plasma membrane and mitochondria. Inhibition of calpain
and the mitochondrial NCXs showed similar degrees of
neuroprotection compared with caspase 3 inhibition.
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Prolonged exposure to salinomycin induces cell death
in DRGNs. Salinomycin in the dose range of 1–10mM has
been shown to be highly effective in the elimination of
CSCs.
2 We therefore tested whether these concentrations
would impair cell viability in primary rat DRGNs. To discover
early cellular alterations, we studied cells treated for 8h and
additionally assayed cell viability after 24h, as early changes
in cell death have been shown to be potentially reversible
(reviewed by Galluzzi et al.
9). A typical event of early
apoptosis is the exposure of phosphatidylserine (PS) on the
outer leaﬂet of the plasma membrane, which can be
visualized by live-cell staining using ﬂuorophore-conjugated
annexin-V. DRGNs were treated for 8h with 10mM
salinomycin or vehicle (DMSO), and then labeled with
annexin-V–enhanced green ﬂuorescent protein (EGFP).
Exposure to salinomycin led to a signiﬁcantly higher
number of annexin-V-positive DRGNs compared with
control (41±5%; 749/6; versus 10±1%; 785/6; P¼0.002;
Figure 1a). To further investigate whether prolonged
exposure to salinomycin exerts cytotoxic effects in the low
micromolar dose range, we investigated cell viability by
means of a multiplexed assay measuring the activity of the
mitochondrial dehydrogenase as well as protease activity
released from dead cells. After incubation for 24h with 1 and
10mM salinomycin or vehicle, cell viability was decreased to
27±1% (n¼9; Po0.001) for 1mM and 15±2% (n¼9;
Po0.001) for 10mM salinomycin compared with vehicle
control (100±7%, n¼9; Figure 1b). Taken together, these
results show that salinomycin in micromolar concentrations
exerts marked toxicity against peripheral neurons.
Effects of salinomycin on cytosolic Na
þ and Ca
2þ
concentrations in DRGNs. Given its ionic properties, we
hypothesized that the observed neurotoxic effects are
because of a disruption of the intracellular ion homeostasis.
As salinomycin transports Na
þ more efﬁciently than K
þ,
1 we
monitored cytosolic Na
þ changes in DRGNs using the
ratiometric ﬂuorescent Na
þ sensitive dye SBFI/AM. Addition
of salinomycin but not vehicle lead to a rapid increase of the
SBFI ratio, which reached a new steady state (Figure 2a).
The average increase in SBFI ratio as compared with
baseline, a measure that correlates to cytosolic Na
þ
concentrations, after addition of 10mM salinomycin was
0.41±0.03 (29/5) and 0.03±0.01 in vehicle-treated cells
(Po0.001; 33/5).
Ca
2þ is an intracellular messenger that is involved in the
regulation of many cellular functions, including cell death, and
has been reported to be altered in the myocardium after
salinomycin treatment.
7 We thus hypothesized that a de-
ranged Ca
2þ homeostasis might be an important event in
salinomycin-induced neurotoxicity. Cytosolic Ca
2þ concen-
trations were measured in DRGNs loaded with the ratiometric
Ca
2þ indicator Fura-2/AM. Treatment with salinomycin lead
to an average increase of 329±47nM in cytosolic Ca
2þ (36/
6) as compared with 10±2nM (36/6) in vehicle-treated cells
(Po0.05; Figure 2b).
One possible explanation for the observed increase in
cytosolic Ca
2þ is that elevated cytosolic Na
þ concentrations
cause a depolarization of the membrane potential, leading
to a secondary Ca
2þ inﬂux through voltage-gated Ca
2þ
channels (VGCCs). We inhibited the VGCCs and most other
Ca
2þ-permeable channels in the plasma membrane
using 0.5mM CdCl2 prior to salinomycin exposure, which
however did not have a signiﬁcant effect on the response
amplitude (301±33nM; 36/6; Figure 2b). In order to
determine the contribution of extracellular Ca
2þ to this signal,
cells were analyzed in a Ca
2þ-free solution. This pretreat-
mentdidnotabolishtheresponse,buttheresponseamplitude
was signiﬁcantly decreased to 61±8nM (Figure 2c; Po0.05;
36/6).
Figure 1 Salinomycin induces cell death in DRGNs. (a) Cells were exposed to 10mM salinomycin or vehicle for 8h and stained with annexin-V–EGFP, a ﬂuorescent
marker for plasma membrane asymmetry. The vehicle-treated cells (upper panel) were mainly annexin-V-negative, whereas many salinomycin-treated cells (lower panel)
showed a strong ﬂuorescence signal (arrows). (b) DRGNs were treated with various concentrations of salinomycin or vehicle for 24h. Cell viability was measured with a
multiplexedassaymeasuringtheactivityofthemitochondrialdehydrogenaseaswellasproteaseactivityreleasedfromdeadcells.Salinomycintreatmentresultedinamarked
reduction of cell viability. *Po0.05
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Cell Death and DiseaseTo further dissect the mechanism of salinomycin-induced
increase in cytosolic Ca
2þ, we used thapsigargin, an inhibitor
of the sarcoplasmic–endoplasmic reticulum (ER) Ca
2þ
ATPase, to deplete Ca
2þ stored in the ER. After the initial
Ca
2þ release from the ER, the cytosolic Ca
2þ concentrations
returned to baseline levels, but addition of 10mM salinomycin
still elicited a response of 30±3nM (33/5; Figure 2d, dashed
line). These results suggest that the initiation of the response
to salinomycin does not depend on Ca
2þ stored in the ER.
Another important buffer for Ca
2þ ions are mitochondria.
Addition of the mitochondrial-uncoupler FCCP (10mM) lead to
arapidreleaseofmitochondrial Ca
2þ (ﬁrst peakinFigure2e);
further addition of 10mM salinomycin showed an almost
completely abrogated response (2±0.6nM; Po0.05 com-
pared with both thapsigargin and vehicle pretreatment, 36/6;
Figure 2e). By contrast, stimulation with 200mM ATP still
elicited a response after FCCP pretreatment (110±28nM;
Po0.05 compared with salinomycin, 26/6; Figure 2e).
Taken together, these results suggest that the increase of
cytosolic Ca
2þ induced by salinomycin is partly mediated by
inﬂux over the plasma membrane and partly by release of
Ca
2þ stored in mitochondria.
Salinomycin-induced Ca
2þ changes are mediated by
NCXs in the plasma membrane and mitochondria. In the
presence of high levels of cytosolic Na
þ, the NCXs in the
Figure 2 Salinomycin leads to increased cytosolic Na
þ and Ca
2þ concentrations. (a) Salinomycin application (ﬁrst arrow) leads to a rapid increase of cytosolic Na
þ
concentrations (solid line) in DRGNs. Vehicle treatment shows no effect (ﬁrst arrow, dashed line) compared with later addition of salinomycin (second arrow, dashed line).
(b) A representative Ca
2þ response to treatment (arrow) with 10mM salinomycin (solid line) or vehicle (dashed line). Inhibition of VGCCs with CdCl2 does not affect the
salinomycin-induced increase in cytosolic Ca
2þ (gray dotted line). (c) In the absence of extracellular Ca
2þ, addition of salinomycin (arrow, solid line) but not vehicle (arrow,
dashed line) leads to a transient increase in cytosolic Ca
2þ.( d) After depletion of ER Ca
2þ stores with thapsigargin, addition of salinomycin still elicits a response (arrow,
dashedline, cellspretreatedwith vehicle).By contrast,pre-incubationwith CGP,a selectiveinhibitorof mitochondrial NCXs,leadstoa signiﬁcantlyreducedCa
2þ transient in
response to salinomycin afterthapsigargintreatment(arrow,solidline). (e)Ca
2þ isreleasedfrommitochondrialstoresinresponsetothemitochondrialuncouplerFCCP(ﬁrst
peak).Subsequentapplication(arrow)ofsalinomycin(solidline),vehicle(dashedline)orATP(dottedline)showsanalmostcompletelyabrogatedresponsetosalinomycinbut
not ATP. (f) Pre-incubation with SN-6, an inhibitor of the NCXs in the plasma membrane (solid line), CGP (dotted line), or SN-6, and CGP combined (gray short-dashed line)
leads to a signiﬁcant reduction of the response amplitude compared with vehicle pre-incubation (dashed line) after application of 10mM salinomycin (arrow)
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Cell Death and Diseaseplasma membrane and mitochondria can go into a ‘reverse
mode’ leading to accumulation of Ca
2þ in the cytosol. In
order to test this hypothesis, DRGNs were pre-incubated with
CGP-37157 (CGP), which is a selective inhibitor of the
mitochondrial NCXs.
10 To avoid confounding Ca
2þ signals
from other sources, mitochondrial Ca
2þ release in response
to 10mM salinomycin was measured under Ca
2þ-free
conditions and after depletion of ER Ca
2þ stores. Under
these conditions the response in CGP-treated cells was
signiﬁcantly reduced compared with that in vehicle-treated
cells (12.8±1.1nM, Po0.05, 34/6; Figure 2d). In the
presence of extracellular Ca
2þ, pretreatment with 10mM
CGP also resulted in a signiﬁcantly smaller Ca
2þ signal
(176±41nM; Po0.05 compared with vehicle pretreatment,
34/6; Figure 2f). Incubation with 30mM of SN-6, an inhibitor of
the NCXs in the plasma membrane,
11 reduced the response
amplitude to 124±11nM (Po0.05, 36/6; Figure 2f).
Combined treatment with SN-6 and CGP almost completely
abrogated the response (44±4nM, Po0.05, 36/6;
Figure 2f).
In summary, these data support the hypothesis that
increased cytosolic Ca
2þ concentrations in response to
salinomycin are mediated by NCXs in the plasma membrane
and mitochondria, which change to a reverse mode of action
owing to cytosolic Na
þ accumulation.
Salinomycin treatment activates calpain, caspase 12,
caspase 9 and caspase 3. Increased cytosolic Ca
2þ
concentrations can induce cell death by various
mechanisms: one potential mechanism is the activation of
the Ca
2þ-activated protease calpain in mitochondria,
resulting in the release of apoptosis-inducing factor (AIF),
which in turn triggers caspase-independent cell death.
12 In
order to investigate this possibility, we visualized AIF in
DRGNs treated with a vehicle or salinomycin for 8h. In either
case, AIF showed typical mitochondrial localization and
similar staining intensities, which indicates that AIF is not
relevant for salinomycin-induced cell death in DRGNs
(Figure 3a).
Figure 3 Salinomycin treatment does not alter the localization of AIF but induces the loss of cytochrome c in DRGNs. (a) Representative micrographs of cells treated for
8h with vehicle (upper row) or 10mM salinomycin (SAL; lower row). In the ﬁrst panel AIF was visualized with an Alexa-488-conjugated secondary antibody (green); in the
second panel cytochrome c was detected with an Alexa-546-coupled secondary antibody (red); in the third panel DNA was stained with DAPI (blue); and the fourth panel
shows an overlay of the previous images. AIF (green) shows similar staining patterns in vehicle- as well as salinomycin-treated cells, whereasthe cytochrome c signal (red) is
greatly reduced. (b) Representative micrographs of cells treated for 8h with vehicle (upper row) or 10mM salinomycin (SAL, lower row). In the ﬁrst panel cytochrome c was
visualized with an FITC-conjugated secondary antibody (green); in the second panel respiratory chain complex V subunit a was detected with an Alexa-633-coupled
secondary antibody (red); in the third panel DNA was stained with DAPI (blue); in the fourth panel images were overlaid. Cytochrome c (green) staining is greatly reduced in
some of the salinomycin-treated cells (white arrows), whereas staining of respiratory chain complex V subunit a is similar, suggesting release of cytochrome c from
mitochondria in these cells
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Cell Death and DiseaseAnother putative mechanism is the activation of calpain in
the cytoplasm, which can cause cellular damage leading to
necrosis as well as activation of caspase 12.
13 In order to
explore this possibility, we measured calpain activation 8h
after treatment with 10mM salinomycin. Calpain activity
was signiﬁcantly higher in salinomycin-treated cells
(128±4%) as compared with that in vehicle-treated controls
(100±3%, Po0.001(n¼5)). Thecalpain inhibitor AK295has
previously been shown to be protective in DRGNs with a
deranged intracellular Ca
2þ homeostasis.
14 Incubation
with 10mM AK295 prevented the increased calpain activity
in salinomycin-treated cells (99±2%; Po0.001 compared
with salinomycin treatment (n¼5); Figure 4a). By contrast,
treatment of cells with AK295 alone did not have a
signiﬁcant effect on the activity of calpain or the studied
caspases as compared with the control (Figure 4a–d). Co-
incubation of DRGNs with 10mM AK295 as well as various
concentrations of salinomycin signiﬁcantly improved cell
viability (Figure 4e).
Normalized caspase 12 activity in DRGNs after 8h of
salinomycin treatment was 126±5% as compared with
100±4% after vehicle treatment (n¼7; P¼0.004). This
effect could be completely inhibited by co-incubation with
the calpain inhibitor AK295 (92±5%; Figure 4b).
It is known that caspase 12 activates caspase 9, which in
turn activates the ‘effector’ caspase 3. We were therefore
interested to ﬁnd out whether caspase 9 activity is increased
in salinomycin-treated DRGNs. Normalized caspase 9
activity was 161±2% in cells treated with 10mM salinomycin
for 8h as compared with that in vehicle-treated cells
(100±4%,Po0.001 (n¼5)). Interestingly, this effect was
inhibited only partially by co-incubation with AK295, suggest-
ing additional means of caspase 9 activation (Figure 4c).
Similar results were obtained for caspase 3, which showed
marked activation after 8h exposure to 10mM salinomycin
(780±37%; n¼5) as compared with the vehicle (100±16%,
Po0.001 (n¼5)). This effect could be inhibited completely by
the caspase 3 inhibitor AC-DEVD-CHO (C3-I) at a concentra-
tion of 10mM, but again only partial inhibition was achieved
with AK295 (Figure 4d). Accordingly, treatment of DRGNs
with the same caspase 3 inhibitor signiﬁcantly improved
(Po0.05) normalized cell viability to 70±4% (n¼9) in cells
treated with 1mM salinomycin and 53±4% (n¼9) in cells
treated with 10mM salinomycin as compared with that in the
control (Figure 4e).
Previous ﬁndings from cats suffering from salinomycin
intoxication indicated that salinomycin, in addition to axonal
damage, also destroys the myelin sheath.
5 We therefore
investigated whether salinomycin in the low micromolar
concentration range would impair cell viability in a culture of
primary rat Schwann cells. Schwann cells showed a more
pronounced reduction in cell viability as compared with
DRGNs after exposure to 10mM salinomycin, but were less
affectedbythelowerdose(Figure5a).Activationofcaspase9
and caspase 3 showed a similar pattern as compared with
DRGNs (Figures 5b and c).
Figure 4 Salinomycin treatment activates calpain, caspase 12, caspase 9 and caspase 3. (a) Treatment of DRGNs with 10mM salinomycin for 8h leads to a signiﬁcant
increase in calpain activity. This effect can be prevented with the calpain inhibitor AK295. (b) A similar pattern of activation is observed for caspase 12 activity, which can also
beblockedwithAK295.Caspase9andcaspase3activityisincreasedafterincubationofDRGNswith10mMsalinomycinfor8h(candd),aneffectthatisonlypartlyinhibited
by the calpain inhibitor AK295. (d) Treatment with the caspase 3 inhibitor C3-I prevents salinomycin-induced caspase 3 activation (1mM/10mM indicates incubation with
differentsalinomycinconcentrations).(e)Co-incubationofDRGNswithvariousconcentrationsof salinomycinand10mMAK295,10mMC3-I,10mMCGP,or10mMCGPand
10mM AK295 for 24h signiﬁcantly improves cell viability. The combination of CGP and AK295 showed comparable effectiveness to the caspase 3 inhibitor (C3-I). *Po0.05
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Cell Death and DiseaseThese results suggest that caspase-mediated cell death
has an important role in salinomycin-mediated neurotoxicity.
Caspase activation appears to be, at least in part, induced by
calpain-mediated caspase 12 cleavage, which then triggers
the downstream caspases.
Inhibition of the mitochondrial NCXs prevents
salinomycin-induced DWm dissipation and cytochrome
c release. It has been reported previously that salinomycin
inhibits mitochondrial respiration in isolated mitochondria
8
and affects the mitochondrial membrane potential (DCm)i n
spermatozoa.
15 We thus hypothesized that in DRGNs
salinomycin might also dissipate DCm, which typically
precedes cytochrome c release (reviewed by Green and
Reed
16). Cytochrome c is in turn capable of forming a
complex with APAF-1, which leads to the activation of
caspase 9. Mitochondrial membrane potential was
measured using the cationic ﬂuorescent dye JC-1 by ﬂow
cytometry. This dye undergoes a red–green shift of its
ﬂuorescence, which correlates with a decrease in the
mitochondrial membrane potential. DRGNs treated with
10mM salinomycin for 8h showed a marked reduction of
red JC-1 ﬂuorescence (Figure 6a) compared with that in
vehicle-treated controls. Interestingly, this effect could be
inhibited with CGP, an inhibitor of mitochondrial NCXs
(Figures 6a and b).
In a next step, we studied cytochrome c release from
mitochondria. Cytochrome c was visualized in DRGNs
receiving vehicle or salinomycin treatment for 8h. In salino-
mycin-treated cells cytochrome c ﬂuorescence was de-
creased, with many cells showing only a faint signal
compared with that in control cells, which suggests that
cytochrome c release took place in cells exposed to
salinomycin (Figures 3a and b). In order to further character-
ize this effect, we isolated mitochondrial protein fractions from
DRGNs treated for 24h with vehicle, 10mM salinomycin,
10mM salinomycin and 10mM CGP, or 10mM CGP alone.
Cytochrome c immunoreactivity normalized to the loading
control (a-subunit of respiratory chain complex V) showed a
signiﬁcant decrease to 45±4% (n¼4) in salinomycin-treated
cells versus 91±14% in salinomycin- and CGP-, and
100±3% in vehicle-treated cells (Po0.05; Figures 6c and
d). Incubation with CGP alone neither elicited a signiﬁcant
changeinDCmnorincytochromeclevels.Theseresultsshow
a protective effect of CGP on the mitochondrial membrane
potential and cytochrome c release in salinomycin-treated
cells.WenexttestedwhetherinhibitionofmitochondrialNCXs
wouldimprovecellviability.Co-incubationwithCGPimproved
normalized cell viability to 51±3% (n¼9) for 1mM salinomy-
cin and 43±4% for 10mM salinomycin (Po0.05; Figure 4e).
These ﬁndings suggest a dual activation mechanism of
caspase 9 in salinomycin-treated DRGNs, through calpain
and caspase 12 on the one and cytochrome c on the other
hand. Indeed, similar levels of cell viability for 1 or 10mM
salinomycin were observed in DRGNs treated with C3-I, or
those subjected to combined AK295 and CGP treatment,
lending support to this hypothesis (Figure 4e).
Discussion
The aim of this study was to investigate the effects of
salinomycin in low micromolar concentrations on the cell
viability and ional homeostasis of DRGNs. We observed loss
of plasma membrane asymmetry suggestive of early apopto-
sisafter8handamarkedreductionofcellviabilityafter24hof
salinomycin treatment. Investigation of the underlying mole-
cular pathomechanism showed that salinomycin mediated an
increase of cytosolic Na
þ and Ca
2þ concentrations. This is
most likely because of the ionic properties of salinomycin,
which have been characterized extensively in previous
studies.
1 Further dissection of the Ca
2þ signal showed
Ca
2þ inﬂux across the plasma membrane as well as release
from mitochondrial stores. This effect was mediated by the
NCXs in the plasma membrane and mitochondria, which
reverse their mode of action in the presence of high cytosolic
Na
þ concentrations. Depletion of Ca
2þ stored in the ER
leads to a decreased response amplitude compared with that
under Ca
2þ-free conditions alone. This could be because of
Ca
2þ depletion by prolonged maintenance of cells under
Ca
2þ buffering conditions. Alternatively, the Ca
2þ signal
originating in the mitochondria might be ampliﬁed through
ryanodine receptor-mediated, Ca
2þ-induced Ca
2þ release
from the ER. Downstream from these events we observed the
activation of the Ca
2þ-activated protease calpain, which
in turn cleaved caspase 12. Caspases are activated in a
sequential manner and caspase 12 is upstream from caspase
Figure 5 Salinomycin impairs cell viability and activates caspase 9 and
caspase 3 in primary Schwann cells. (a) Schwann cells were treated with various
concentrations of salinomycin or vehicle (control) for 24h. Cell viability was
measured with a multiplexed assay measuring the activity of the mitochondrial
dehydrogenase as well as protease activity released from dead cells. Salinomycin
treatmentresultedinamarkedreductionofcellviability.Thiseffectcouldbevariably
inﬂuenced by inhibition of mitochondrial NCXs (10mM CGP), calpain (10mM
AK295) or caspase 3 (10mM C3-I). (b) Increased caspase 9 and caspase 3 activity
is measured after incubation of Schwann cells with 10mM salinomycin for 8h
(b and c), showing a similar pattern compared to DRGNs. *Po0.05
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Cell Death and Disease9 and the ‘effector’ caspase 3. Whereas inhibition of calpain
completely prevented caspase 12 activation, it suppressed
caspase 9 and caspase 3 activity only partially, suggesting an
alternative pathway for caspase 9 activation.
A well-characterized mechanism of pro-caspase 9
cleavage is through a complex formed by cytochrome c
released from mitochondria, dATP and APAF-1.
17 We
observedthat DRGNs treatedwith salinomycinhad a reduced
mitochondrial membrane potential and signiﬁcantly reduced
cytochrome c levels in the mitochondrial fraction. Interest-
ingly, inhibition of mitochondrial NCXs prevented loss of
mitochondrial membrane potential as well as cytochrome c
release, suggesting that in the studied concentration range
theseeffectsaremediatedbythemitochondrial NCXsandnot
bydirect salinomycin actionas observed in isolatedmitochon-
dria.
8 These effects would support a model where caspase 9
is activated by a dual mechanism through both cytochrome
c and caspase 12 mediated pathways (Figure 7).
Further support for this model comes from the observation
that inhibition of caspase 3 signiﬁcantly improves cell
viability, which allows the conclusion that cell death
especially at lower salinomycin concentrations is conferred
by caspase-mediated apoptotic cell death. The smaller effect
of caspase inhibition on cell survival at higher salinomycin
concentrations might be because of a metabolic overload
resulting from tonically elevated cytosolic Na
þ levels.
Combined inhibition of calpain and mitochondrial NCXs
lead to cell viability comparable with caspase 3 inhibition,
supporting dual activation of caspase 9.
Little is known about the effects of salinomycin on the
human organism. One published case of salinomycin inges-
tion in man led to polyneuropathy but also rhabdomyolysis.
4
As plasma concentrations were not determined, it remains
unclear whether damage to striated muscles has to be
expected in the dose range of the current study. However, in
1996 food contaminated with salinomycin at a concentration
of approximately 30mM led to widespread manifestation of
sensorimotor polyneuropathy but not rhabdomyolysis in
cats.
5,18 Therefore, it is likely that that at nanomolar or low
micromolar concentrations neurotoxic side effects are pre-
dominant. We infer from these anecdotal observations and
our data that salinomycin in the studied concentration range
bears a signiﬁcant potential to cause severe peripheral
neuropathy in humans, which is highly relevant when this
Figure 6 Inhibition of mitochondrial NCXs prevents salinomycin-induced DCm dissipation and cytochrome c release. (a) Flow cytometric measurement of red JC-1
ﬂuorescence correlates with the mitochondrial membrane potential DCm. DRGNs were treated for 8h with vehicle (thick solid line), 10mM salinomycin (SAL, long dashed
line), 10mM salinomycin and 10mM CGP, an inhibitor of mitochondrial NCXs (SALþCGP, short dashedline), 10mM CGP alone (dottedline), or for 30min with 50mM of the
mitochondrial uncoupler FCCP (FCCP, thin line). The data have been presented as normalized histogram. Salinomycin leads to a decreased mitochondrial membrane
potential DCm, which can be prevented by co-incubation with CGP. Cells with ﬂuorescence greater than 10
2 (arbitrary units, AU) were classiﬁed as JC-1-positive and
normalized to control to compare the depolarization induced by salinomycin (b). (c) A representative western blot of the mitochondrial fraction of DRGNs treated for 24h with
vehicle,10mM salinomycin (SAL), 10mM salinomycin and10mM CGP (SALþCGP),or 10mM CGP,andprobedfor cytochromecand respiratory chaincomplexV subunit a
(loading control). Decreased cytochrome c immunoreactivity is detected after salinomycin treatment. This effect is inhibited by co-incubation with CGP. (d) Normalized
cytochrome c immunoreactivity is signiﬁcantly reduced in salinomycin-treated cells. *Po0.05
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Cell Death and Diseasetoxin is tested as a drug in patients. The preferential
occurrence of toxic side effects in the peripheral nervous
system may be explained by the observation that
P-glycoprotein limits the brain penetration of salinomycin.
19
Our ﬁndings introduce a pathomechanism for salinomycin-
induced neurotoxicity in the concentration range shown to be
effective against CSCs. One central question in this regard is,
whether this pathomechanism differs from the mechanism of
action against CSCs. Gupta etal.,
2 who identiﬁed salinomycin
ina high-throughputscreen, showedthatsalinomycininduces
a profound change in the gene expression of CSCs.
Speciﬁcally, they observed reduced expression of genes
associated with CSCs and increased expression of cell
adhesion proteins such as cadherins. This suggests the
conclusion that in CSCs salinomycin leads to terminal
epithelial differentiation and subsequent cell-cycle arrest
rather than direct cytotoxic effects, which were observed in this
study with neuronal cells. How salinomycin induces these
changesingeneexpressionremainstobeelucidated;however,
the mechanism of action is hypothesized to result from
interference with the cellular K
þ homeostasis. In fact, in line
with this notion, K
þ channels have been shown to be relevant
for tumor proliferation and migration (reviewed by Beug
20). If
this holds true, the pathogenesis of neurotoxic side effects
would be different from the mode of action against CSCs,
enabling neuroprotective strategies without compromise in
antitumor activity. Based on our results, a preventive co-
treatment with inhibitors of mitochondrial NCXs might allow the
use of higher salinomycin concentrations with less neurotoxic
side effects, providing a better chance for CSC elimination.
Inthecontextofpolyneuropathyresearch,ourobservations
underline the importance of a deranged Ca
2þ homeostasis.
We have recently shown that the cytostatic drug paclitaxel
induces Ca
2þ oscillations in neuronal cells,
21 which leads to
Ca
2þ-mediated calpain activation.
14 It was shown previously
that calpain inhibition prevents paclitaxel-induced neuropathy
in vivo.
22 Taken together, these ﬁndings emphasize the
importance of altered intracellular Ca
2þ concentrations in the
pathogenesis of peripheral neurodegeneration. Our present
study further elucidates signal cascades downstream from
calpain activation and additionally highlights the role of
mitochondrial dysfunction for the induction of cell death in
peripheral neurons. Intriguingly, the combination of a dis-
turbed Ca
2þ homeostasis and mitochondrial malfunction,
although likely initiated by different mechanisms, has also
been implied as an important factor in diabetic neuropathy
(reviewed by Verkhratsky and Fernyhough
23). This suggests
a more general role of these factors in the pathogenesis of
polyneuropathy worth further exploration.
We report that exposure of dorsal root ganglia with low
micromolar concentrations of salinomycin disturbs the in-
tracellular Na
þ and Ca
2þ homeostasis, resulting in calpain
and caspase activation leading to cell death. These ﬁndings
expand our knowledge of the mechanisms involved in the
pathogenesis of salinomycin-induced peripheral neuropathy
and provide a mechanism for neuroprotection through
inhibition of mitochondrial NCXs. As a result, new strategies
for a clinical translation of salinomycin therapy may be
developed.
Materials and Methods
Cell culture
DRGNculture. Allexperimentalproceduresconformedtoinstitutionalguidelines
and were approved by an ofﬁcial committee (LaGeSo; T0119/10). DRGNs isolated
from rat neonates (P1–3) were digested in 0.28 Wu ¨nsch unit collagenase (Liberase
DL;Roche, Mannheim, Germany)andseparated bygentle trituration.Thetriturated
cells were passed through a 70-mm cell strainer to remove cell clumps, followed by
Percoll gradient centrifugation (1.019/1.038g/ml) at 1000 g for 10min. DRGNs
wereplated on poly-L-lysine/laminin-coatedcoverslips andmaintainedas described
previously.
14
Schwann cell culture. All experimental procedures conformed to institutional
guidelines and were approved by an ofﬁcial committee (LaGeSo; T0119/10).
Schwann cells were isolated from postnatal rat sciatic nerves (P3) and cultured as
described previously.
24
Live-cell imaging
Fura-2. Cells were cultured on eight-well Ibidi m-Slides (Ibidi GmbH, Martinsried,
Germany) with and loaded with 5mM Fura-2/AM (Molecular Probes, Invitrogen,
Darmstadt, Germany) at 371C for 30min in a standard solution containing (in mM)
130NaCl,4.7KCl,1MgSO4,1.2KH2PO4,1.3CaCl2,20 HEPESand5glucose(pH
7.4), and 0.02% pluronic F-127 (Molecular Probes, Invitrogen). After loading, Fura-2 was
allowed to de-esterify for at least 10min at room temperature in a standard solution. Cells
were monitored using an inverted Olympus IX71 stage equipped with a UPLSAPO X2
 40/0.95 objective (Olympus, Hamburg, Germany). Fluorescence data were acquired
using a PC running Cell^M software (Olympus) by means of a cooled CCD camera
(ORCA; Hamamatsu, Herrsching am Ammersee, Germany). Unless cells were treated
with thapsigargin or FCCP, addition of 10mM ionomycin at the end of the experiment was
used as an internal control.
Cytosolic free Ca
2þ concentration ([Ca
2þ]int) was calculated as described
previously.
14 Experiments in the absence of Ca
2þ were conducted in Ca
2þ-free
HEPES buffer containing (in mM) 130 NaCl, 4.7 KCl, 2.3 MgSO4, 1.2 KH2PO4,1 0
EGTA, 20 HEPES and 5 glucose (pH 7.4). All substances were bath-applied.
Figure 7 Summary of the observed effects of salinomycin-induced toxicity in
DRGNs. Salinomycin leads to an increase of cytosolic Na
þ concentrations, with a
subsequent increase in cytosolic Ca
2þ, which is mediated by NCXs in the plasma
membrane and mitochondria. Elevated intracellular Ca
2þ levels activate the
protease calpain, which triggers apoptotic cell death by the activation of caspase
pathwaysinvolvingcaspase12,caspase9andcaspase3.Caspase9isadditionally
activated by cytochrome c released from depolarized mitochondria
Salinomycin-induced neuronal cell death
W Boehmerle and M Endres
8
Cell Death and DiseaseSBFI. Cells were cultured on eight-well Ibidi m-Slides with and loaded with 7mM
SBFI/AM (Molecular Probes, Invitrogen) at 371C for 30min in the same standard
solution as described above. After loading, SBFI/AM was allowed to de-esterify for
at least 10min at room temperature in a standard solution. Cells were monitored
as described above for Fura-2. The SBFI ratio was calculated from whole-cell
ﬂuorescence of background-subtracted images acquired at a wavelength of 340nm
and 380nm. Increase in SBFI ratio of each cell was calculated by subtracting the
baselineratiofromthestimulatedratio.Forcomparisontheaverageofthismeasure
was calculated for different treatment conditions.
Assessment of DWm. Cell suspensions with 1.5 10
5 freshly isolated
DRGNs were incubated for 8h at 371C with vehicle, salinomycin,
salinomycinþCGP, CGP or left untreated. Thereafter, cells were loaded with the
cationic dye JC-1 at 0.1mM for 30min, followed by centrifugation for 5min at
300 g and resuspension in buffer containing 1% BSA in phosphate-buffered
saline (PBS) (pH 7.4). The untreated samples were additionally incubated with
50mM FCCP as a depolarized control. Analysis was performed with a
‘FACSCalibur’ (BD Biosciences, Heidelberg, Germany) ﬂow cytometer, where JC-
1 was excited by an argon laser (488nm) and green (530/30nm) as well as red
ﬂuorescence (585/42nm) was detected simultaneously. Data were analyzed using
the FlowJo software (Tree Star Inc., Ashland, OR, USA).
Cell viability assays
Annexin-V labeling. Cells were incubated on a 48-well plate for 8h with vehicle
or salinomycin. Annexin-V labeling was performed and analyzed using EGFP-
conjugated annexin-V (MBL, Woburn, MA, USA) according to the manufacturer’s
protocol.Annexin-V–EGFPstainingwasvisualizedusinganinvertedLeicaDM3000
epiﬂourescencemicroscope(Leica,Wetzlar,Germany).Twoimagesweretakenper
well and the number of annexin-V-positive cells was counted.
CytoTox-Fluor cytotoxicity assay. This assay measures a distinct protease
activity associated with cytotoxicity and uses a ﬂuorogenic peptide substrate
(bis-alanyl-alanyl-phenylanlanyl-rhodamine 110 (bis-AAF-R110)) to assess
protease activity that has been released from cells that have lost membrane
integrity (Promega, Mannheim, Germany). This assay was performed prior to MTT
assay, by pipetting 50ml of supernatant from treated cells on a 96-well plate,
followed by addition of 50ml of substrate and incubation for 1h at 371C.
Fluorescence was measured using a ﬂuorescence microplate reader (CytoFluor;
Perseptive Biosystems, Carlsbad, CA, USA), using 480±20nm as the excitation and
525±20nm as the emission wavelength. The values were background-subtracted and
a compound measure for cell viability was calculated as described below.
MTT assay. Metabolic integrity of cells was assessed using MTT as described
previously.
25 The MTT assay correlates with the number of live cells, whereas the
CytoTox-Fluor assay correlates with the number of dead cells. In order to increase
sensitivity, both assays where combined by dividing background-subtracted MTT
absorbance values by the background-subtracted values of the cytotoxicity assay.
The values were then normalized to control.
Cell fractionation and western blot analysis. Puriﬁed cytosolic,
nuclear and mitochondrial fractions were obtained using the Cell fractionation kit
HT (Mitosciences, Eugene, OR, USA) following the manufacturer’s protocol.
Immunoblotting was performed as described previously.
26 The antibodies used
were as follows: anti-cytochrome c and anti-complex-V-a (both from Mitosciences).
BlotswerequantiﬁedbyscanningdensitometryusingtheImageJsoftware(National
Institutesof Health, Bethesda, MD, USA), by normalizing the cytochrome c levels in
the mitochondrial fraction to the complex-V-a loading control. All western blot
experiments were performed using three independent cultures unless stated
otherwise.
Protease assays
Calpain activity assay. Calpain activity was assessed as described
previously.
27 Cells were grown in 96-well plates and incubated for 30min with
inhibitors as well as the Suc-LLVY-aminoluciferin calpain substrate at 20mM,
followed by treatment with salinomycin or vehicle (DMSO). After 8h of treatment,
cellswerelysedwith0.9%TritonX-100inpresenceof0.1mMMDL-28170,apotent
inhibitor of calpain-1 and calpain-2. After addition of the CalpainGLO luciferase
detection reagent from the Calpain Glo protease assay (Promega) luminescence
was detected using a Berthold Centro LB 960 microplate reader (Berthold,
Scho ¨neiche/Berlin, Germany).
Caspase-3/7 assay. Caspase-3 activity was measured by the Apo-ONE
homogeneous caspase-3/7 assay (Promega) according to the manufacturer’s
protocol.
Caspase-9 assay. Caspase-9 activity was measured using the Caspase-Glo 9
assay system (Promega) as described in the manufacturer’s protocol.
Caspase-12 assay. Caspase-12 activity was measured with a ﬂuorometric
caspase-12 assay kit (Promokine; Promocell, Heidelberg, Germany) according to
manufacturer’s instructions.
Immunocytochemistry of DRGNs. DRGNs were cultivated on poly-L-
lysine- and laminin-coated coverslips. After ﬁxation with 4% paraformaldehyde in
PBS, cells were permeabilized with 0.1% Triton X-100. Unspeciﬁc binding sites
were blocked with 10% normal goat serum (NGS) and proteins of interest were
identiﬁed with a primary antibody diluted in 10% NGS at 41C overnight. In each
experimenta negativecontrolwithouta primaryantibodywas included.Theprimary
antibodies were detected with a ﬂuorophore coupled secondary antibody and
mounted with the ProLong Gold antifade reagent with DAPI (Molecular Probes,
Invitrogen). The specimens were visualized with a Leica TCS SPE upright confocal
microscope. The antibodies used were as follows: Primary antibodies-
anti-cytochrome c and anti-complex-V-a (both from Mitosciences), and anti-AIF
(Epitomics, Burlingame, CA, USA); secondary antibodies-anti-mouse IgG2a-FITC
(Mitosciences); anti-mouse IgG2b-Alexa-633, anti-mouse IgG-Alexa-546 and
anti-rabbit IgG-Alexa-488 (all from Molecular Probes, Invitrogen).
Statistical analysis. Data are expressed as the means±S.E.M. or as
representative traces. (n/N) describes the number of cells studied (n)i n( N)
independentcultures.Statisticalanalysisofthedifferencesbetweenmultiplegroups
was performedbyone-wayANOVAandfor twogroupsbyt-test (SigmaStat;Systat,
Richmond, CA, USA). Po0.05 was considered statistically signiﬁcant.
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